QuiVad

Home / Italy / CTI Biopharma Corp

CTI Biopharma Corp

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 2.77% on July 27, 2015. The shaded band is the year shown above.

November 30, 2012 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

163 disclosures on record for this share.
DateFund% of capitalEnd of publication
October 24, 2013The Goldman Sachs Group, Inc.0.61%still open
October 22, 2013The Goldman Sachs Group, Inc.0.55%still open
October 17, 2013The Goldman Sachs Group, Inc.0.66%still open
October 15, 2013The Goldman Sachs Group, Inc.0.70%still open
October 14, 2013The Goldman Sachs Group, Inc.0.67%still open
October 9, 2013The Goldman Sachs Group, Inc.0.71%still open
October 4, 2013The Goldman Sachs Group, Inc.0.85%still open
October 3, 2013The Goldman Sachs Group, Inc.0.60%still open
October 2, 2013The Goldman Sachs Group, Inc.0.57%still open
September 26, 2013Two Sigma Investments, LP0.46%still open
September 23, 2013Two Sigma Investments, LP0.50%still open
September 20, 2013Two Sigma Investments, LP0.49%still open
September 18, 2013Two Sigma Investments, LP0.50%still open
September 17, 2013Two Sigma Investments, LP0.49%still open
September 16, 2013Two Sigma Investments, LP0.51%still open
August 19, 2013Two Sigma Investments, LP0.49%still open
July 9, 2013Two Sigma Investments, LP0.50%still open
July 1, 2013The Goldman Sachs Group, Inc.0.35%still open
June 28, 2013The Goldman Sachs Group, Inc.0.59%still open
May 31, 2013Two Sigma Investments, LP0.49%still open
May 10, 2013Two Sigma Investments, LP0.59%still open
April 25, 2013The Goldman Sachs Group, Inc.0.49%still open
April 22, 2013The Goldman Sachs Group, Inc.0.53%still open
April 19, 2013The Goldman Sachs Group, Inc.0.68%still open
April 17, 2013The Goldman Sachs Group, Inc.0.73%still open
April 17, 2013Two Sigma Investments, LP0.60%still open
April 16, 2013The Goldman Sachs Group, Inc.0.80%still open
April 15, 2013The Goldman Sachs Group, Inc.0.73%still open
April 12, 2013The Goldman Sachs Group, Inc.1.14%still open
April 11, 2013The Goldman Sachs Group, Inc.1.28%still open
April 10, 2013The Goldman Sachs Group, Inc.0.85%still open
April 3, 2013Two Sigma Investments, LP0.50%still open
March 28, 2013The Goldman Sachs Group, Inc.0.96%still open
March 27, 2013The Goldman Sachs Group, Inc.1.04%still open
March 22, 2013The Goldman Sachs Group, Inc.0.98%still open
March 1, 2013The Goldman Sachs Group, Inc.1.07%still open
February 26, 2013The Goldman Sachs Group, Inc.1.17%still open
February 22, 2013The Goldman Sachs Group, Inc.1.25%still open
February 20, 2013The Goldman Sachs Group, Inc.1.18%still open
February 15, 2013The Goldman Sachs Group, Inc.1.23%still open
February 12, 2013The Goldman Sachs Group, Inc.1.00%still open
February 8, 2013The Goldman Sachs Group, Inc.0.99%still open
February 1, 2013The Goldman Sachs Group, Inc.1.01%still open
January 30, 2013The Goldman Sachs Group, Inc.0.99%still open
January 25, 2013The Goldman Sachs Group, Inc.1.01%still open
January 22, 2013The Goldman Sachs Group, Inc.0.94%still open
January 10, 2013The Goldman Sachs Group, Inc.0.00%still open
January 9, 2013The Goldman Sachs Group, Inc.1.00%still open
January 4, 2013The Goldman Sachs Group, Inc.1.38%still open
December 28, 2012The Goldman Sachs Group, Inc.1.29%still open

Other companies sold short in Italy

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, CTI Biopharma Corp, source Consob, data as at June 14, 2017, https://www.quivad.com/action/cti-biopharma-corp?page=3